ENvue Medical, Inc.
FEED- Exchange
- OTC
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001326706
No open-market purchases or sales by ENvue Medical, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $149.2K in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding ENvue Medical, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 0 | 6 | +6 |
| Shares | 0 | 1.68K | +1.68K |
| Value | $0 | $9.50K | +$9.50K |
New holders (6)
Institutions that held ENvue Medical, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Morgan Stanley | 1,000 | $5.64K | 0.00% |
| Tower Research Capital LLC (TRC) | 627 | $3.54K | 0.00% |
| UBS Group AG | 35 | $198 | 0.00% |
| SBI Securities Co., Ltd. | 15 | $85 | 0.00% |
| Bank of America Corp | 6 | $34 | 0.00% |
| Citigroup Inc | 1 | $6 | 0.00% |
Sold out (0)
Institutions that held ENvue Medical, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
None.